Louis W. Sullivan
Louis W. Sullivan, M.D. has served as a director of Emergent BioSolutions "since June 2006. Dr. Sullivan has served as president emeritus of Morehouse School of Medicine since July 2002. Dr. Sullivan served as president of Morehouse School of Medicine from 1981 to 1989 and from 1993 to 2002. From 1989 to 1993, Dr. Sullivan was Secretary of HHS. Dr. Sullivan also serves on the boards of directors of United Therapeutics Corporation, BioSante Pharmaceuticals, Inhibitex, Inc. and Henry Schein, Inc., publicly traded biotechnology companies. He is a founder and chairman of Medical Education for South African Blacks, Inc., a trustee of Morehouse School of Medicine and Africare and a director of the National Center on Addiction and Substance Abuse at Columbia University. Dr. Sullivan recently retired from the boards of directors of Bristol-Myers Squibb Company, 3-M Corporation, Georgia Pacific Corporation, Cigna Corporation and Equifax, Inc. Dr. Sullivan received his M.D. from Boston University and a B.S. from Morehouse College." [1]
- Director, Points of Light Foundation
- Fleishman-Hillard International Advisory Board
- Director, Project HOPE
- Honorary Director, Prostate Cancer Foundation [2]
Resources and articles
Related Sourcewatch articles
References
- ↑ Louis W. Sullivan, Emergent BioSolutions, accessed July 7, 2009.
- ↑ Prostate Cancer Foundation Honorary Board, organizational web page, accessed July 11, 2013.